1
|
Longo JPF, Muehlmann LA. Application of Nanomedicine in Immunotherapy: Recent Advances and Prospects. Pharmaceutics 2023; 15:1910. [PMID: 37514096 PMCID: PMC10383970 DOI: 10.3390/pharmaceutics15071910] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2023] [Accepted: 06/22/2023] [Indexed: 07/30/2023] Open
Abstract
Nanomedicine is a special medical field focused on the application of nanotechnology to provide innovations for healthcare in different areas, including the treatment of a wide variety of diseases, including cancer [...].
Collapse
Affiliation(s)
- João Paulo Figueiró Longo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasilia 70910-900, Brazil
| | | |
Collapse
|
2
|
Graván P, Aguilera-Garrido A, Marchal JA, Navarro-Marchal SA, Galisteo-González F. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Adv Colloid Interface Sci 2023; 314:102871. [PMID: 36958181 DOI: 10.1016/j.cis.2023.102871] [Citation(s) in RCA: 14] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 02/03/2023] [Accepted: 03/06/2023] [Indexed: 03/11/2023]
Abstract
Nanotechnological drug delivery platforms represent a new paradigm for cancer therapeutics as they improve the pharmacokinetic profile and distribution of chemotherapeutic agents over conventional formulations. Among nanoparticles, lipid-based nanoplatforms possessing a lipid core, that is, lipid-core nanoparticles (LCNPs), have gained increasing interest due to lipid properties such as high solubilizing potential, versatility, biocompatibility, and biodegradability. However, due to the wide spectrum of morphologies and types of LCNPs, there is a lack of consensus regarding their terminology and classification. According to the current state-of-the-art in this critical review, LCNPs are defined and classified based on the state of their lipidic components in liquid lipid nanoparticles (LLNs). These include lipid nanoemulsions (LNEs) and lipid nanocapsules (LNCs), solid lipid nanoparticles (SLNs) and nanostructured lipid nanocarriers (NLCs). In addition, we present a comprehensive and comparative description of the methods employed for their preparation, routes of administration and the fundamental role of physicochemical properties of LCNPs for efficient antitumoral drug-delivery application. Market available LCNPs, clinical trials and preclinical in vivo studies of promising LCNPs as potential treatments for different cancer pathologies are summarized.
Collapse
Affiliation(s)
- Pablo Graván
- Department of Applied Physics, Faculty of Science, University of Granada, 18071 Granada, Spain; Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, 18016 Granada, Spain; Instituto de Investigación Biosanitaria de Granada ibs.GRANADA, 18012 Granada, Spain; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, 18016 Granada, Spain; Excellence Research Unit Modelling Nature (MNat), University of Granada, 18016 Granada, Spain; BioFab i3D - Biofabrication and 3D (bio)printing laboratory, University of Granada, 18100 Granada, Spain
| | - Aixa Aguilera-Garrido
- Department of Applied Physics, Faculty of Science, University of Granada, 18071 Granada, Spain
| | - Juan Antonio Marchal
- Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, 18016 Granada, Spain; Instituto de Investigación Biosanitaria de Granada ibs.GRANADA, 18012 Granada, Spain; Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, 18016 Granada, Spain; Excellence Research Unit Modelling Nature (MNat), University of Granada, 18016 Granada, Spain; BioFab i3D - Biofabrication and 3D (bio)printing laboratory, University of Granada, 18100 Granada, Spain
| | - Saúl A Navarro-Marchal
- Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, 18016 Granada, Spain; Excellence Research Unit Modelling Nature (MNat), University of Granada, 18016 Granada, Spain; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, EH4 2XU Edinburgh, UK.
| | | |
Collapse
|
3
|
de Oliveira JV, Oliveira da Rocha MC, de Sousa-Junior AA, Rodrigues MC, Farias GR, da Silva PB, Bao SN, Bakuzis AF, Azevedo RB, Morais PC, Muehlmann LA, Figueiró Longo JP. Tumor vascular heterogeneity and the impact of subtumoral nanoemulsion biodistribution. Nanomedicine (Lond) 2022; 17:2073-2088. [PMID: 36853205 DOI: 10.2217/nnm-2022-0176] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023] Open
Abstract
Aim: Investigate the heterogeneous tumor tissue organization and examine how this condition can interfere with the passive delivery of a lipid nanoemulsion in two breast cancer preclinical models (4T1 and Ehrlich). Materials & methods: The authors used in vivo image techniques to follow the nanoemulsion biodistribution and microtomography, as well as traditional histopathology and electron microscopy to evaluate the tumor structural characteristics. Results & conclusion: Lipid nanoemulsion was delivered to the tumor, vascular organization depends upon the subtumoral localization and this heterogeneous organization promotes a nanoemulsion biodistribution to the highly vascular peripherical region. Also, the results are presented with a comprehensive mathematical model, describing the differential biodistribution in two different breast cancer models, the 4T1 and Ehrlich models.
Collapse
Affiliation(s)
| | | | | | - Mosar Corrêa Rodrigues
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | - Gabriel Ribeiro Farias
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | | | - Sônia Nair Bao
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | | | - Ricardo Bentes Azevedo
- Institute of Biological Sciences, University of Brasília, Brasília, DF, 70910-900, Brazil
| | - Paulo César Morais
- Institute of Physics, University of Brasília, Brasília, DF, 70910-900, Brazil
- Biotechnology & Genomic Sciences, Catholic University of Brasília, Brasília, DF, 70790-160, Brazil
| | | | | |
Collapse
|
4
|
Pinheiro WO, Costa do Santos MS, Farias GR, Fascineli ML, Ramos KLV, Duarte ECB, Damasceno EAM, da Silva JR, Joanitti GA, de Azevedo RB, Sousa MH, Lacava ZGM, Mosiniewicz-Szablewska E, Suchocki P, Morais PC, de Andrade LR. Combination of selol nanocapsules and magnetic hyperthermia hinders breast tumor growth in aged mice after a short-time treatment. NANOTECHNOLOGY 2022; 33:205101. [PMID: 35100566 DOI: 10.1088/1361-6528/ac504c] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2021] [Accepted: 01/31/2022] [Indexed: 06/14/2023]
Abstract
Short time treatment with reduced dosages of selol-loaded PLGA nanocapsules (NcSel) combined with magnetic hyperthermia (MHT) is evaluated in aged Erhlich tumor-bearing mice. Clinical, hematological, biochemical, genotoxic and histopathological parameters are assessed during 7 d treatment with NcSel and MHT, separately or combined. The time evolution of the tumor volume is successfully modeled using the logistic mathematical model. The combined therapy comprising NcSel and MHT is able to hinder primary tumor growth and a case of complete tumor remission is recorded. Moreover, no metastasis was diagnosed and the adverse effects are negligible. NcSel plus MHT may represent an effective and safe alternative to cancer control in aged patients. Future clinical trials are encouraged.
Collapse
Affiliation(s)
- Willie Oliveira Pinheiro
- University of Brasilia, Post-Graduation Program in Sciences and Technologies in Health, Faculty of Ceilandia, 72220-275, Brasilia, DF, Brazil
- University of Brasilia, Faculty of Ceilandia, Green Nanotechnology Group, 72220-900 Brasilia, DF, Brazil
| | | | - Gabriel Ribeiro Farias
- University of Brasilia, Laboratory of Immunology and Inflammation, Department of Cell Biology, 70910-900 Brasilia, DF, Brazil
| | - Maria Luiza Fascineli
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
- Department of Morphology (DMORF), Health Science Center, Federal University of Paraíba, 58051-900, João Pessoa, Brazil
| | - Khellida Loiane Vieira Ramos
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | | | | | - Jaqueline Rodrigues da Silva
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | - Graziella Anselmo Joanitti
- University of Brasilia, Laboratory of Bioactive Compounds and Nanobiotechnology (LBCNano), Faculty of Ceilandia, 72220-275 Brasilia-DF, Brazil
| | - Ricardo Bentes de Azevedo
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | - Marcelo Henrique Sousa
- University of Brasilia, Faculty of Ceilandia, Green Nanotechnology Group, 72220-900 Brasilia, DF, Brazil
| | - Zulmira Guerrero Marques Lacava
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| | | | - Piotr Suchocki
- Department of Bioanalysis and Drug Analysis, Medical University of Warsaw, Warsaw, Poland
| | - Paulo Cesar Morais
- University of Brasília, Institute of Physics, Brasília DF 70910-900, Brazil
- Catholic University of Brasília, Genomic Sciences and Biotechnology, Brasília DF 70790-160, Brazil
| | - Laise Rodrigues de Andrade
- University of Brasilia, Institute of Biological Sciences, Department of Genetics and Morphology, 70910-900 Brasilia, DF, Brazil
| |
Collapse
|
5
|
Shreyash N, Sonker M, Bajpai S, Tiwary SK. Review of the Mechanism of Nanocarriers and Technological Developments in the Field of Nanoparticles for Applications in Cancer Theragnostics. ACS APPLIED BIO MATERIALS 2021; 4:2307-2334. [PMID: 35014353 DOI: 10.1021/acsabm.1c00020] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Cancer cannot be controlled by the usage of drugs alone, and thus, nanotechnology is an important technique that can provide the drug with an impetus to act more effectively. There is adequate availability of anticancer drugs that are classified as alkylating agents, hormones, or antimetabolites. Nanoparticle (NP) carriers increase the residence time of the drug, thereby enhancing the survival rate of the drug, which otherwise gets washed off owing to the small size of the drug particles by the excretory system. For example, for enhancing the circulation, a coating of nonfouling polymers like PEG and dextran is done. Famous drugs such as doxorubicin (DOX) are commonly encapsulated inside the nanocomposite. The various classes of nanoparticles are used to enhance drug delivery by aiding it to fight against the tumor. Targeted therapy aims to attack the cells with features common to the cancer cells while minimizing damage to the normal cell, and these therapies work in one in four ways. Some block the cancer cells from reproducing newer cells, others release toxic substances to kill the cancer cells, some stimulate the immune system to destroy the cancer cells, and some block the growth of more blood vessels around cancer cells, which starve the cells of the nutrients, which is needed for their growth. This review aims to testify the advancements nanotechnology has brought in cancer therapy, and its statements are supported with recent research findings and clinical trial results.
Collapse
|
6
|
Mosiniewicz-Szablewska E, Tedesco AC, Suchocki P, Morais PC. Magnetic studies of polylactic- co-glicolic acid nanocapsules loaded with selol and γ-Fe 2O 3 nanoparticles. Phys Chem Chem Phys 2021; 22:21042-21058. [PMID: 32926060 DOI: 10.1039/d0cp02706e] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The as-prepared (MSE-NCs sample) and lyophilized (LMSE-NCs sample) polylactic-co-glicolic acid (PLGA) nanocapsules loaded with maghemite (γ-Fe2O3) nanoparticles and selol (Se-based anticancer drug) were investigated by means of dc magnetization, ac susceptibility and electron spin resonance (ESR) measurements over the temperature range of 4-300 K. The magnetic data of the as-synthesized nanocapsules containing only maghemite nanoparticles (M-NCs sample) or selol (SE-NCs sample) were also collected for comparison. The magnetic nanocapsules reveal perfect superparamagnetic (SPM) behavior only around room temperature; at temperatures lower than 200 K the SPM scaling is not observed and all samples behave as interacting superparamagnetic (ISPM) materials. The evolution from the ISPM to the SPM regime is marked by a steady decrease in the hysteretic properties of all samples, with the temperature dependence of the coercivity decreasing slower than the T1/2 behavior predicted for non-interacting SPM particles. The SPM character of the samples is also confirmed by the occurrence of a maximum in the temperature dependence of both real χ'(T) and imaginary χ''(T) components of the ac magnetic susceptibility, which shifts towards higher temperatures with increasing frequency. Moreover, upon decreasing the temperature the ESR signal shifts to lower fields and gradually broadens, following closely the predictions for the ESR of SPM particles. Additionally, an unusual giant diamagnetic response is observed at low temperatures. The ZFC magnetization is found to reverse its direction and becomes diamagnetic, whereas the FC branch remains positive. Even when compared with usual superconductors, the order of the diamagnetic susceptibility for the lyophilized sample (-10-2 emu g-1 Oe-1) is quite considerable. The nanocapsules herein reported and the presented analysis of their magnetic properties we envisage can support the engineering of magnetic nanocapsules for applications in magnetic drug delivery systems and as magnetic hyperthermia inductors in antitumor therapy.
Collapse
|
7
|
Karabasz A, Bzowska M, Szczepanowicz K. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature. Int J Nanomedicine 2020; 15:8673-8696. [PMID: 33192061 PMCID: PMC7654520 DOI: 10.2147/ijn.s231477] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Accepted: 10/06/2020] [Indexed: 12/14/2022] Open
Abstract
Polymeric nanomaterials have become a prominent area of research in the field of drug delivery. Their application in nanomedicine can improve bioavailability, pharmacokinetics, and, therefore, the effectiveness of various therapeutics or contrast agents. There are many studies for developing new polymeric nanocarriers; however, their clinical application is somewhat limited. In this review, we present new complex and multifunctional polymeric nanocarriers as promising and innovative diagnostic or therapeutic systems. Their multifunctionality, resulting from the unique chemical and biological properties of the polymers used, ensures better delivery, and a controlled, sequential release of many different therapeutics to the diseased tissue. We present a brief introduction of the classical formulation techniques and describe examples of multifunctional nanocarriers, whose biological assessment has been carried out at least in vitro. Most of them, however, also underwent evaluation in vivo on animal models. Selected polymeric nanocarriers were grouped depending on their medical application: anti-cancer drug nanocarriers, nanomaterials delivering compounds for cancer immunotherapy or regenerative medicine, components of vaccines nanomaterials used for topical application, and lifestyle diseases, ie, diabetes.
Collapse
Affiliation(s)
- Alicja Karabasz
- Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland
| | - Monika Bzowska
- Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland
| | - Krzysztof Szczepanowicz
- Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Kraków, Poland
| |
Collapse
|
8
|
Coelho JM, Camargo NS, Ganassin R, Rocha MCO, Merker C, Böttner J, Estrela-Lopis I, Py-Daniel KR, Jardim KV, Sousa MH, Ombredane AS, Joanitti GA, Silva RC, Azevedo RB, Longo JPF, Muehlmann LA. Oily core/amphiphilic polymer shell nanocapsules change the intracellular fate of doxorubicin in breast cancer cells. J Mater Chem B 2020; 7:6390-6398. [PMID: 31642844 DOI: 10.1039/c9tb00587k] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
The aim of this work was to develop and test the in vitro biological activity of nanocapsules loaded with a doxorubicin (DOX) free base dissolved in a core of castor oil shelled by poly(methyl vinyl ether-co-maleic anhydride) conjugated to n-octadecylamine residues. This system was stable and monodisperse, with a hydrodynamic diameter of about 300 nm. These nanocapsules changed the intracellular distribution of DOX, from the nuclei to the cytoplasm, and exhibited higher toxicity towards cancer cells - 4T1 and MCF-7 - and significantly lower toxicity towards normal cells - NIH-3T3 and MCF-10A - in vitro. In conclusion, these nanocapsules are suitable DOX carriers, which remain to be studied in in vivo tumor models.
Collapse
Affiliation(s)
- Janaina Moreira Coelho
- Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil. and Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | - Nichollas Serafim Camargo
- Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil. and Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | - Rayane Ganassin
- Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil. and Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | - Márcia Cristina Oliveira Rocha
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | - Carolin Merker
- Institute of Medical Physics & Biophysics, Leipzig University, Leipzig 04107, Germany
| | - Julia Böttner
- Institute of Medical Physics & Biophysics, Leipzig University, Leipzig 04107, Germany
| | - Irina Estrela-Lopis
- Institute of Medical Physics & Biophysics, Leipzig University, Leipzig 04107, Germany
| | - Karen Rapp Py-Daniel
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | | | | | - Alicia Simalie Ombredane
- Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil. and Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil and Laboratory of Bioactive Compounds and Nanobiotechnology, Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil
| | - Graziella Anselmo Joanitti
- Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil. and Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil and Laboratory of Bioactive Compounds and Nanobiotechnology, Faculty of Ceilandia, University of Brasilia, Brasilia 72220-900, Brazil
| | - Renata Carvalho Silva
- Institute of Metrology, Quality and Technology (Inmetro), Rio de Janeiro, 20250-020, Brazil
| | - Ricardo Bentes Azevedo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | - João Paulo Figueiró Longo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil
| | | |
Collapse
|
9
|
F Longo JP, Lucci CM, Muehlmann LA, Azevedo RB. Nanomedicine for cutaneous tumors – lessons since the successful treatment of the Kaposi sarcoma. Nanomedicine (Lond) 2018; 13:2957-2959. [DOI: 10.2217/nnm-2018-0374] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Affiliation(s)
- João Paulo F Longo
- Genetics & Morphology Department, Institute of Biological Science, University of Brasilia, Brasília DF 70910-900, Brazil
| | - Carolina M Lucci
- Physiological Sciences Department, Institute of Biological Science, University of Brasilia, Brasília DF 70910-900, Brazil
| | - Luís A Muehlmann
- Faculty of Ceilândia, University of Brasilia, Brasilia 72220-900, Brazil
| | - Ricardo B Azevedo
- Genetics & Morphology Department, Institute of Biological Science, University of Brasilia, Brasília DF 70910-900, Brazil
| |
Collapse
|
10
|
Radicchi MA, de Oliveira JV, Mendes ACP, de Oliveira DM, Muehlmann LA, Morais PC, Azevedo RB, Longo JPF. Lipid nanoemulsion passive tumor accumulation dependence on tumor stage and anatomical location: a new mathematical model for in vivo imaging biodistribution studies. J Mater Chem B 2018; 6:7306-7316. [DOI: 10.1039/c8tb01577e] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nanoparticle delivery to tumor tissue is one of the most important applications of nanomedicine.
Collapse
Affiliation(s)
- Marina Arantes Radicchi
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - Jaqueline Vaz de Oliveira
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - Ana Clara Pova Mendes
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - Daniela Mara de Oliveira
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | | | - Paulo Cesar Morais
- Institute of Physics
- University of Brasilia
- Brasília DF 70910-900
- Brazil
- School of Chemistry and Chemical Engineering
| | - Ricardo Bentes Azevedo
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| | - João Paulo Figueiró Longo
- Department of Genetics and Morphology
- Institute of Biological Science
- University of Brasilia
- Brasília DF 70910-900
- Brazil
| |
Collapse
|